These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 14728109)

  • 1. The economic burden of depression in the United States: how did it change between 1990 and 2000?
    Greenberg PE; Kessler RC; Birnbaum HG; Leong SA; Lowe SW; Berglund PA; Corey-Lisle PK
    J Clin Psychiatry; 2003 Dec; 64(12):1465-75. PubMed ID: 14728109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of depression in 1990.
    Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
    J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of schizophrenia in the United States in 2002.
    Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
    J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of depression in Sweden from 1997 to 2005.
    Sobocki P; Lekander I; Borgström F; Ström O; Runeson B
    Eur Psychiatry; 2007 Apr; 22(3):146-52. PubMed ID: 17194573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
    Greenberg PE; Fournier AA; Sisitsky T; Pike CT; Kessler RC
    J Clin Psychiatry; 2015 Feb; 76(2):155-62. PubMed ID: 25742202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018).
    Greenberg PE; Fournier AA; Sisitsky T; Simes M; Berman R; Koenigsberg SH; Kessler RC
    Pharmacoeconomics; 2021 Jun; 39(6):653-665. PubMed ID: 33950419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
    Mannino DM; Roberts MH; Mapel DW; Zhang Q; Lunacsek O; Grabich S; van Stiphout J; Meadors BL; Feigler N; Pollack MF
    Chest; 2024 May; 165(5):1093-1106. PubMed ID: 38042365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
    Sullivan PW; Follin SL; Nichol MB
    Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression: a neglected major illness.
    Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
    J Clin Psychiatry; 1993 Nov; 54(11):419-24. PubMed ID: 8270584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
    Scitovsky AA; Rice DP
    J Med Pract Manage; 1988; 3(4):234-41. PubMed ID: 10314299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Costs of Diabetes in the U.S. in 2022.
    Parker ED; Lin J; Mahoney T; Ume N; Yang G; Gabbay RA; ElSayed NA; Bannuru RR
    Diabetes Care; 2024 Jan; 47(1):26-43. PubMed ID: 37909353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of depression.
    Stoudemire A; Frank R; Hedemark N; Kamlet M; Blazer D
    Gen Hosp Psychiatry; 1986 Nov; 8(6):387-94. PubMed ID: 3491775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update: direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(18):388-9. PubMed ID: 15138399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of selected digestive diseases in the United States.
    Sandler RS; Everhart JE; Donowitz M; Adams E; Cronin K; Goodman C; Gemmen E; Shah S; Avdic A; Rubin R
    Gastroenterology; 2002 May; 122(5):1500-11. PubMed ID: 11984534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Economic Burden of Asthma in the United States, 2008-2013.
    Nurmagambetov T; Kuwahara R; Garbe P
    Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.